Date prepared: December 9, 2021
Abbreviated name of the issuer: CELON PHARMA S.A.
Subject: Notification about transactions on shares of Celon Pharma S.A.
Legal basis: Article 19 section 3 of the Market Abuse Regulation (MAR) – information on transactions conducted by persons discharging managerial responsibilities.
Content of the report:
The Management Board of Celon Pharma S.A. (the “Company”) hereby informs that on December 9, 2021, Glatton Sp. z o.o. – a person closely related to the person discharging managerial responsibilities, i.e. Mr. Maciej Wieczorek – President of the Management Board of Celon Pharma S.A., sent a notification on transactions conducted on the Company's shares.
The Company provides the notification in the attachment to this report.